TY - JOUR T1 - Carrier-Mediated Uptake of YM155 Monobromide, 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide, a Novel Small-molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells JF - Drug Metabolism and Disposition JO - Drug Metab Dispos DO - 10.1124/dmd.108.025254 AU - Tsuyoshi Minematsu AU - Megumi Iwai AU - Kenji Sugimoto AU - Nobuaki Shirai AU - Takahito Nakahara AU - Takashi Usui AU - Hidetaka Kamimura Y1 - 2008/12/04 UR - http://dmd.aspetjournals.org/content/early/2008/12/04/dmd.108.025254.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -